Scholarly Index
John P. DeVincenzo
Enanta Pharmaceuticals (United States); 9,426 total citations; 181 total publications; best world rank #251
Enanta Pharmaceuticals (United States)
9,426Total citations
181Total publications
52H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Respiratory viral infections research | Lifetime | 251 | US 137 | 98.93 |
| Tracheal and airway disorders | Lifetime | 599 | US 321 | 98.08 |
| Neonatal Respiratory Health Research | Lifetime | 952 | US 474 | 97.85 |
| Congenital Diaphragmatic Hernia Studies | Lifetime | 454 | US 260 | 97.55 |
| Pneumonia and Respiratory Infections | Lifetime | 967 | US 362 | 97.06 |
| Parvovirus B19 Infection Studies | Lifetime | 700 | US 305 | 93.71 |